Le Lézard
Classified in: Health

Chiropractic: the Proven Alternative to Opiates and Surgery for Pain



ST. LOUIS, Oct. 5, 2017 /PRNewswire/ -- In the wake of the national opiate abuse crisis, October marks National Chiropractic Health Month (NCHM) and provides an important opportunity to educate pain sufferers about the benefits of chiropractic care and its evidence-informed, patient-centered and drug-free approach to wellness.

This year's theme, "Back to Basics," emphasizes simple yet significant strategies for maintaining spinal health throughout a lifetime. Back pain is a major health issue: Up to 80 percent of people will suffer from the malady during their lives, and it is one of the most common reasons patients begin taking medications.

NCHM's message couldn't be more salient ? according to the CDC, more than 90 Americans die each day from opioid abuse and overuse, and the number of deaths from overdoses has quadrupled since 1999. In 2014, more than 13,000 people died from overdoses, and another 2 million abused or were dependent on opioids.

"Chiropractors are uniquely poised to work side-by-side with medical providers to assist patients with chronic pain and rehabilitation after injury," said Clay McDonald, DC, MBA, JD, president of Logan University. "The increasing interest in holistic wellness, improved nutrition and non-drug based solutions to pain all coalesce now, creating the perfect scenario for a renaissance in chiropractic." Further proof of the increasing demand for chiropractic care, Logan University has recently enrolled its largest class of doctor of chiropractic candidates in a decade.

One Logan researcher, Norman Kettner, DC, DACBR, FICC, is widely considered an expert in brain mapping and pain. Dr. Kettner's most recent research published in the journal Brain showed the positive impact acupuncture has on people suffering from carpal tunnel syndrome. Additional evidence supports drug-free approaches to pain treatment, such as a 2017 study in the Journal of American Medical Association which found that spinal manipulation therapy improves pain among patients with acute low back pain.

About National Chiropractic Health Month

National Chiropractic Health Month, an initiative of the American Chiropractic Association (ACA), raises awareness of the benefits of chiropractic care and its national, whole-person, patient-centered and drug-free approach to health and wellness. Learn more at www.acatoday.org/NCHM.

About Logan University

Logan University is dedicated to maximizing human performance through innovative health education.  Since 1935, Logan has remained grounded in chiropractic education?with the flagship Doctor of Chiropractic Degree?and also offers doctorate, masters and bachelor degrees online and on-campus. Logan is located on a sprawling 112-acre campus in Chesterfield, a western suburb of St. Louis. To learn more, visit www.logan.edu.         

 

SOURCE Logan University


These press releases may also interest you

at 05:00
The Pancreatic Cancer Action Network (PanCAN) is proud to announce that Peter Cashion, MBA, has been elected to its Board of Directors. In his new leadership role in the fight against the world's toughest cancer, Cashion brings over 20 years'...

at 05:00
Novasep, a leading supplier of services and technologies for the life sciences industry, is proud to announce today that it has been selected by Tetraphase for the commercial manufacture of the active pharmaceutical ingredient (API) eravacycline, an...

at 04:30
The global contrast media injectors market is expected to reach USD 1.4 billion by 2025, growing at a CAGR of 5.8%, according to a new report by Grand View Research, Inc. Rising demand for minimally invasive surgical procedures is a major factor...

at 04:00
Today, Ascensia Diabetes Care has announced the launch of its upgraded version of the CONTOUR®DIABETES app in the United Kingdom and Ireland. It includes the new My Patterns feature, which can more intelligently analyse blood glucose results received...

at 03:00
Clearbridge BioMedics today announced that its ClearCell® FX1 System is now broadly available in EMEA and APAC regions to complement its direct availability in the US and existing distribution channels. This was made possible through partnerships...

at 03:00
Eyevensys, a clinical stage biotech company developing non-viral gene therapies for ophthalmic diseases, today announced the appointment of Dr. Patricia Zilliox as CEO. Dr. Zilliox, who joined the Eyevensys board in May 2016, has more than 25 years...




News published on 5 october 2017 at 10:15 and distributed by: